Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 5/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.63 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.63 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31555021 | 1.00 | SMYD3 (0.86) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL21490162 | 0.93 | SMYD3 (1.00) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL19701266 | 0.93 | SMYD3 (1.00) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL14782167 | 0.92 | KDM4E (0.79) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL15366968 | 0.87 | SMYD3 (0.67) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL2825577 | 0.80 | SMYD3 (0.58) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL1518413 | 0.80 | SMYD3 (0.58) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL19445672 | 0.79 | KMT2A (0.63) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL1328289 | 0.79 | SMYD3 (0.57) | SMYD3KDM4EMEN1KMT2ARXFP1 | |
| SCHEMBL5606683 | 0.79 | KMT2A (0.74) | MEN1KMT2AROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109761957-B | Hydroxyproline-containing compound and preparation method and application thereof | 西安交通大学 | 2020-05-19 | — | — | CN | claimed |
| CN-109796439-B | Hydroxyproline peptide derivative and preparation method and application thereof | 西安交通大学 | 2020-05-19 | — | — | CN | claimed |
| CN-111574575-B | Quinolone derivative containing macrolide group, preparation method and application | 北京理工大学 | 2022-05-17 | — | — | CN | disclosed |
| CN-111574575-A | Quinolone derivative containing macrolide group, preparation method and application | 北京理工大学 | 2020-08-25 | — | — | CN | disclosed |
| CN-109824582-B | Alanine derivative and preparation method and application thereof | 西安交通大学 | 2020-06-19 | — | — | CN | disclosed |
| CN-109796439-B | Hydroxyproline peptide derivative and preparation method and application thereof | 西安交通大学 | 2020-05-19 | — | — | CN | disclosed |
| CN-109761957-B | Hydroxyproline-containing compound and preparation method and application thereof | 西安交通大学 | 2020-05-19 | — | — | CN | disclosed |
| US-9133158-B2 | Bicyclic dihydroisoquinoline-1-one derivatives | HOFFMAN-LA ROCHE INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-20130143863-A1 | NEW BICYCLIC DIHYDROISOQUINOLINE-1-ONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2013-06-06 | — | — | US | disclosed |
| EP-1517895-B1 | 8-(BIARYL) QUINOLINE PDE4 INHIBITORS | MERCK FROSST CANADA LTD (CA) | 2007-03-14 | — | — | EP | disclosed |
| US-7153968-B2 | 8-(biaryl)quinoline PDE4 inhibitors | MERCK FROSST CANADA, LTD. (CA) | 2006-12-26 | — | — | US | disclosed |
| US-20050234238-A1 | 8-(Biaryl)quinoline pde4 inhibitors | MERCK FROSST CANADA LTD. (CA) | 2005-10-20 | — | — | US | disclosed |
| EP-1517895-A1 | 8-(BIARYL) QUINOLINE PDE4 INHIBITORS | MERCK FROSST CANADA INC. (CA) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004000814-A1 | 8-(BIARYL) QUINOLINE PDE4 INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130143863-A1 | NEW BICYCLIC DIHYDROISOQUINOLINE-1-ONE DERIVATIVES | CYP11B1, CYP11B2, HSD11B1 | SMYD3 4571/4885KDM4E 4266/4885MEN1 478/4885 |
| US-20050234238-A1 | 8-(Biaryl)quinoline pde4 inhibitors | IL4, PDE4A, PDE4C | SMYD3 3594/4885KDM4E 2473/4885MEN1 4605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.